Edwards Lifesciences Common Stock Net 2010-2024 | EW
- Edwards Lifesciences common stock net for the quarter ending March 31, 2024 was $0.652B, a 0.73% increase year-over-year.
- Edwards Lifesciences common stock net for 2023 was $0.651B, a 0.65% increase from 2022.
- Edwards Lifesciences common stock net for 2022 was $0.646B, a 0.67% increase from 2021.
- Edwards Lifesciences common stock net for 2021 was $0.642B, a 0.88% increase from 2020.
Edwards Lifesciences Annual Common Stock Net (Millions of US $) |
|
---|---|
2023 | $651 |
2022 | $646 |
2021 | $642 |
2020 | $636 |
2019 | $218 |
2018 | $215 |
2017 | $212 |
2016 | $243 |
2015 | $239 |
2014 | $129 |
2013 | $126 |
2012 | $124 |
2011 | $120 |
2010 | $117 |
2009 | $76 |
Edwards Lifesciences Quarterly Common Stock Net (Millions of US $) |
|
---|---|
2024-03-31 | $652 |
2023-12-31 | $651 |
2023-09-30 | $650 |
2023-06-30 | $649 |
2023-03-31 | $647 |
2022-12-31 | $646 |
2022-09-30 | $646 |
2022-06-30 | $645 |
2022-03-31 | $643 |
2021-12-31 | $642 |
2021-09-30 | $641 |
2021-06-30 | $640 |
2021-03-31 | $638 |
2020-12-31 | $636 |
2020-09-30 | $635 |
2020-06-30 | $634 |
2020-03-31 | $219 |
2019-12-31 | $218 |
2019-09-30 | $218 |
2019-06-30 | $217 |
2019-03-31 | $216 |
2018-12-31 | $215 |
2018-09-30 | $215 |
2018-06-30 | $214 |
2018-03-31 | $213 |
2017-12-31 | $212 |
2017-09-30 | $212 |
2017-06-30 | $245 |
2017-03-31 | $243 |
2016-12-31 | $243 |
2016-09-30 | $242 |
2016-06-30 | $241 |
2016-03-31 | $240 |
2015-12-31 | $239 |
2015-09-30 | $130 |
2015-06-30 | $130 |
2015-03-31 | $129 |
2014-12-31 | $129 |
2014-09-30 | $128 |
2014-06-30 | $127 |
2014-03-31 | $126 |
2013-12-31 | $126 |
2013-09-30 | $126 |
2013-06-30 | $125 |
2013-03-31 | $125 |
2012-12-31 | $124 |
2012-09-30 | $124 |
2012-06-30 | $123 |
2012-03-31 | $121 |
2011-12-31 | $120 |
2011-09-30 | $120 |
2011-06-30 | $119 |
2011-03-31 | $118 |
2010-12-31 | $117 |
2010-09-30 | $116 |
2010-06-30 | $115 |
2010-03-31 | $77 |
2009-12-31 | $76 |
2009-09-30 | $75 |
2009-06-30 | $75 |
2009-03-31 | $74 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $50.799B | $6.005B |
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $219.482B | 26.59 |
Intuitive Surgical (ISRG) | United States | $131.844B | 79.42 |
DexCom (DXCM) | United States | $50.060B | 75.83 |
IQVIA Holdings (IQV) | United States | $42.279B | 25.07 |
IDEXX Laboratories (IDXX) | United States | $38.873B | 45.31 |
Alcon (ALC) | Switzerland | $38.723B | 28.56 |
STERIS (STE) | Ireland | $20.261B | 23.98 |
Waters (WAT) | United States | $18.737B | 26.89 |
Hologic (HOLX) | United States | $17.905B | 19.76 |
SONOVA HOLDING (SONVY) | Switzerland | $16.708B | 0.00 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $12.452B | 15.38 |
ShockWave Medical (SWAV) | United States | $12.372B | 85.23 |
Sysmex ADR (SSMXY) | Japan | $10.492B | 32.90 |
Teleflex (TFX) | United States | $9.964B | 15.65 |
Penumbra (PEN) | United States | $7.957B | 98.22 |
Masimo (MASI) | United States | $7.091B | 39.77 |
Globus Medical (GMED) | United States | $6.827B | 21.64 |
Glaukos (GKOS) | United States | $4.964B | 0.00 |
TransMedics (TMDX) | United States | $3.847B | 367.50 |
Integer Holdings (ITGR) | United States | $3.678B | 22.22 |
LivaNova (LIVN) | United Kingdom | $3.391B | 20.14 |
PROCEPT BioRobotics (PRCT) | United States | $3.115B | 0.00 |
Elekta AB (EKTAY) | Sweden | $2.700B | 18.52 |
Nihon Kohden (NHNKY) | Japan | $2.423B | 20.49 |
Inari Medical (NARI) | United States | $2.419B | 0.00 |
Tandem Diabetes Care (TNDM) | United States | $2.337B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $2.294B | 9.41 |
RxSight (RXST) | United States | $2.108B | 0.00 |
Alphatec Holdings (ATEC) | United States | $1.813B | 0.00 |
Veracyte (VCYT) | United States | $1.539B | 0.00 |
OPKO Health (OPK) | United States | $0.885B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.868B | 16.06 |
Artivion (AORT) | United States | $0.838B | 96.81 |
Paragon 28 (FNA) | United States | $0.817B | 0.00 |
Silk Road Medical (SILK) | United States | $0.795B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.738B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.671B | 0.00 |
SiBone (SIBN) | United States | $0.598B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.594B | 20.18 |
IRadimed (IRMD) | United States | $0.532B | 30.88 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.487B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.460B | 0.00 |
Pulse Biosciences (PLSE) | United States | $0.420B | 0.00 |
NeuroPace (NPCE) | United States | $0.401B | 0.00 |
Nevro (NVRO) | United States | $0.382B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.341B | 11.47 |
AxoGen (AXGN) | United States | $0.287B | 0.00 |
Sight Sciences (SGHT) | United States | $0.277B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.263B | 0.00 |
AngioDynamics (ANGO) | United States | $0.232B | 0.00 |
CVRx (CVRX) | United States | $0.219B | 0.00 |
Accuray (ARAY) | United States | $0.215B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.192B | 0.00 |
908 Devices (MASS) | United States | $0.187B | 0.00 |
Semler Scientific (SMLR) | United States | $0.184B | 9.90 |
Alpha Tau Medical (DRTS) | Israel | $0.169B | 0.00 |
Inogen (INGN) | United States | $0.166B | 0.00 |
Delcath Systems (DCTH) | United States | $0.150B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.147B | 0.00 |
Neuronetics (STIM) | United States | $0.107B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.103B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.095B | 0.00 |
Envoy Medical (COCH) | United States | $0.087B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.068B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.063B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.062B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.059B | 120.33 |
SEP Acquisition (SEPA) | United States | $0.058B | 0.00 |
Hyperfine (HYPR) | United States | $0.058B | 0.00 |
Yubo Biotech (YBGJ) | China | $0.053B | 0.00 |
Vasomedical (VASO) | United States | $0.050B | 9.00 |
Vicarious Surgical (RBOT) | United States | $0.049B | 0.00 |
InspireMD (NSPR) | Israel | $0.046B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.044B | 0.00 |
DarioHealth (DRIO) | United States | $0.043B | 0.00 |
ReWalk Robotics (LFWD) | Israel | $0.040B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.040B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.040B | 0.00 |
Pixie Dust Technologies (PXDT) | Japan | $0.038B | 0.00 |
LENSAR (LNSR) | United States | $0.035B | 0.00 |
Precision Optics (POCI) | United States | $0.034B | 0.00 |
Spectral AI (MDAI) | United States | $0.030B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.025B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.022B | 0.00 |
PAVmed (PAVM) | United States | $0.022B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.017B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.017B | 0.00 |
Microbot Medical (MBOT) | United States | $0.014B | 0.00 |
NexGel (NXGL) | United States | $0.014B | 0.00 |
Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
Avinger (AVGR) | United States | $0.006B | 0.00 |
Venus Concept (VERO) | Canada | $0.004B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
Tenon Medical (TNON) | United States | $0.003B | 0.00 |
Dynatronics (DYNT) | United States | $0.002B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
Nuwellis (NUWE) | United States | $0.001B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |